ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone734-335-0468
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$10,000.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/21/2019 (Estimated)
OptionableNot Optionable
ENDRA Life Sciences (NASDAQ:NDRA) Frequently Asked Questions
What is ENDRA Life Sciences' stock symbol?
ENDRA Life Sciences trades on the NASDAQ under the ticker symbol "NDRA."
How were ENDRA Life Sciences' earnings last quarter?
When is ENDRA Life Sciences' next earnings date?
Has ENDRA Life Sciences been receiving favorable news coverage?
News stories about NDRA stock have trended negative on Friday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ENDRA Life Sciences earned a media sentiment score of -2.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future.
Who are some of ENDRA Life Sciences' key competitors?
Some companies that are related to ENDRA Life Sciences include Edap Tms (EDAP), IRIDEX (IRIX), Viveve Medical (VIVE), Soleno Therapeutics (SLNO), Digirad (DRAD), Precision Optics (PEYE), Nexeon Medsystems (NXNN), Non-Invasive Monitoring Systems (NIMU), Vaso (VASO), Reshape Lifesciences (RSLS), Aradigm (ARDM), CHF Solutions (CHFS), Escalon Medical (ESMC), Trimedyne (TMED) and Fc Global Realty (FCRE).
What other stocks do shareholders of ENDRA Life Sciences own?
Who are ENDRA Life Sciences' key executives?
ENDRA Life Sciences' management team includes the folowing people:
- Mr. Francois Michelon, Chairman & CEO (Age 53)
- Mr. David R. Wells, Chief Financial Officer (Age 57)
- Mr. Michael Thornton, Chief Technology Officer (Age 51)
- Dr. Jonathan Behr Ph.D., Co-Founder
When did ENDRA Life Sciences IPO?
(NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO.
Who are ENDRA Life Sciences' major shareholders?
ENDRA Life Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include ICM Asset Management Inc. WA (10.12%), Geode Capital Management LLC (0.72%), Geode Capital Management LLC (0.72%), Creative Planning (0.53%) and National Asset Management Inc. (0.35%). View Institutional Ownership Trends for ENDRA Life Sciences.
Which institutional investors are buying ENDRA Life Sciences stock?
NDRA stock was bought by a variety of institutional investors in the last quarter, including ICM Asset Management Inc. WA, Geode Capital Management LLC, Geode Capital Management LLC, Creative Planning and National Asset Management Inc.. View Insider Buying and Selling for ENDRA Life Sciences.
How do I buy shares of ENDRA Life Sciences?
Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ENDRA Life Sciences' stock price today?
One share of NDRA stock can currently be purchased for approximately $3.13.
How big of a company is ENDRA Life Sciences?
ENDRA Life Sciences has a market capitalization of $20.75 million and generates $10,000.00 in revenue each year.
What is ENDRA Life Sciences' official website?
How can I contact ENDRA Life Sciences?
ENDRA Life Sciences' mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected]
MarketBeat Community Rating for ENDRA Life Sciences (NASDAQ NDRA)
MarketBeat's community ratings are surveys of what our community members think about ENDRA Life Sciences and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
